Pajjiż: Olanda
Lingwa: Olandiż
Sors: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
CARBIDOPA 1-WATER 20,2 mg/stuk SAMENSTELLING overeenkomend met ; CARBIDOPA 0-WATER 18,8 mg/stuk ; ENTACAPONE 200 mg/stuk ; LEVODOPA 75 mg/stuk
Lannacher Heilmittel GmbH Schlossplatz 1 A-8502 LANNACH (OOSTENRIJK)
N04BA03
CARBIDOPA 1-WATER 20,2 mg/stuk SAMENSTELLING overeenkomend met ; CARBIDOPA 0-WATER 18,8 mg/stuk ; ENTACAPONE 200 mg/stuk ; LEVODOPA 75 mg/stuk
Filmomhulde tablet
CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; CROSCARMELLOSE NATRIUM (E 468) ; GLYCEROL (E 422) ; HYPROLOSE (E 463) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; IJZEROXIDE ROOD (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; POLOXAMEER 188 ; POLYSORBAAT 80 (E 433) ; TITAANDIOXIDE (E 171), CELLULOSE, MICROKRISTALLIJN (E 460) ; CROSCARMELLOSE NATRIUM (E 468) ; GLYCEROL (E 422) ; HYPROLOSE (E 463) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; IJZEROXIDE ROOD (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; POLOXAMEER 188 ; POLYSORBAAT 80 (E 433) ; TITAANDIOXIDE (E 171),
Oraal gebruik
Levodopa, Decarboxylase Inhibitor And Comt Inhibitor
Hulpstoffen: CELLULOSE, MICROKRISTALLIJN (E 460); CROSCARMELLOSE NATRIUM (E 468); GLYCEROL (E 422); HYPROLOSE (E 463); HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464); IJZEROXIDE ROOD (E 172); LACTOSE 1-WATER; MAGNESIUMSTEARAAT (E 470b); POLOXAMEER 188; POLYSORBAAT 80 (E 433); TITAANDIOXIDE (E 171);
1900-01-01
PACKAGE LEAFLET: INFORMATION FOR THE USER LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 50 MG/12,5 MG/200 MG FILMOMHULDE TABLETTEN LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 75 MG/18,75 MG/200 MG FILMOMHULDE TABLETTEN LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 100 MG/25MG/200 MG FILMOMHULDE TABLETTEN LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 125 MG/31,25 MG/200 MG FILMOMHULDE TABLETTEN LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 150 MG/37,5 MG/200 MG FILMOMHULDE TABLETTEN LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 175 MG/43,75 MG/200 MG FILMOMHULDE TABLETTEN LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER 200 MG/50 MG/200 MG FILMOMHULDE TABLETTEN levodopa/carbidopa/entacapone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Levodopa/Carbidopa/Entacapone Lannacher is and what it is used for 2. What you need to know before you take Levodopa/Carbidopa/Entacapone Lannacher 3. How to take Levodopa/Carbidopa/Entacapone Lannacher 4. Possible side effects 5. How to store Levodopa/Carbidopa/Entacapone Lannacher 6. Contents of the pack and other information 1. WHAT LEVODOPA/CARBIDOPA/ENTACAPONE LANNACHER IS AND WHAT IT IS USED FOR Levodopa/Carbidopa/Entacapone Lannacher contains three active substances (levodopa, carbidopa and entacapone) in one film-coated tablet. Levodopa/Carbidopa/Entacapone Lannacher is used for the treatment of Parkinson’s disease. Parkinson’s disease is caused by low levels of a substance called dopamine in the brain. Levodopa increases the amount of dopamine and hence reduces the symptoms of Parkinson Aqra d-dokument sħiħ
1. NAME OF THE MEDICINAL PRODUCT Levodopa/Carbidopa/Entacapone Lannacher 50 mg/12,5 mg/200 mg filmomhulde tabletten Levodopa/Carbidopa/Entacapone Lannacher 75 mg/18,75 mg/200 mg filmomhulde tabletten Levodopa/Carbidopa/Entacapone Lannacher 100 mg/25mg/200 mg filmomhulde tabletten Levodopa/Carbidopa/Entacapone Lannacher 125 mg/31,25 mg/200 mg filmomhulde tabletten Levodopa/Carbidopa/Entacapone Lannacher 150 mg/37,5 mg/200 mg filmomhulde tabletten Levodopa/Carbidopa/Entacapone Lannacher 175 mg/43,75 mg/200 mg filmomhulde tabletten Levodopa/Carbidopa/Entacapone Lannacher 200 mg/50 mg/200 mg filmomhulde tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 50 mg of levodopa, 12.5 mg of carbidopa anhydrous (as 13.5mg Carbidopa monohydrate) and 200 mg of entacapone. Each film-coated tablet contains 75 mg of levodopa, 18.75 mg of carbidopa anhydrous (as 20.24 mg Carbidopa monohydrate) and 200 mg of entacapone. Each film-coated tablet contains 100 mg of levodopa, 25 mg of carbidopa anhydrous (as 27 mg Carbidopa monohydrate) and 200 mg of entacapone. Each film-coated tablet contains 125 mg of levodopa, 31.25 mg of carbidopa anhydrous (as 33.74 mg Carbidopa monohydrate) and 200 mg of entacapone. Each film-coated tablet contains 150 mg of levodopa, 37.5 mg of carbidopa anhydrous (as 40.48 mg Carbidopa monohydrate) and 200 mg of entacapone. Each film-coated tablet contains 175 mg of levodopa, 43.75 mg of carbidopa anhydrous (as 47.23 mg Carbidopa monohydrate) and 200 mg of entacapone. Each film-coated tablet contains 200 mg of levodopa, 50 mg of carbidopa anhydrous (as 54 mg Carbidopa monohydrate) and 200 mg of entacapone. Excipient with known effect: Each film-coated tablet of 50 mg levodopa/12.5 mg carbidopa anhydrous/200 mg entacapone contains 112 mg of lactose Each film-coated tablet of 75 mg/levodopa/18.75 mg of carbidopa anhydrous/200 mg entacapone contains 124 mg of lactose . Each film-coated tablet of 100 mg levodopa/25 mg of carbidopa anhydrous/200 mg entacapone contains 139 mg of la Aqra d-dokument sħiħ